{"id":4005,"date":"2012-04-24T13:09:00","date_gmt":"2012-04-24T13:09:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=4005"},"modified":"2021-07-12T07:44:33","modified_gmt":"2021-07-12T07:44:33","slug":"combination-therapy-with-adalimumab-plus-intensive-granulocyte-and-monocyte-adsorptive-apheresis-induced-clinical-remission-in-a-crohns-disease-patient-with-the-loss-of-response-to-scheduled","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/combination-therapy-with-adalimumab-plus-intensive-granulocyte-and-monocyte-adsorptive-apheresis-induced-clinical-remission-in-a-crohns-disease-patient-with-the-loss-of-response-to-scheduled\/","title":{"rendered":"Combination therapy with Adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn\u2019s disease patient with the loss of response to scheduled Adalimumab maintenance therapy: A case report"},"content":{"rendered":"
\n

Keiji Ozeki<\/a> 1<\/a><\/sup>, Satoshi Tanida<\/a>, Takashi Mizushima<\/a>, Tsutomu Mizoshita<\/a>, Hironobu Tsukamoto<\/a>, Yoshikazu Hirata<\/a>, Kenji Murakami<\/a>, Takaya Shimura<\/a>, Hiromi Kataoka<\/a>, Takeshi Kamiya<\/a>, Takashi Joh<\/a>, Intern Med. 2012;51(6):595-9.<\/p>\n<\/div>\n\n

\n

A 21-year-old Caucasian man with a diagnosis of Crohn’s disease (CD) at the age of 14 was admitted to our hospital due to CD flare-up while under scheduled adalimumab (ADA) maintenance therapy. His symptoms remained virtually unchanged following high dose corticosteroid therapy. Seven days later, combination therapy with ADA plus intensive granulocyte\/monocyte adsorptive apheresis (GMA) was initiated, which induced clinical remission. Therefore, combination therapy with ADA plus intensive GMA appears to be an effective therapeutic option for patients with severe CD while under scheduled ADA maintenance therapy.<\/p>\n<\/div>\n\n

\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/22449667\/<\/a><\/p>\n<\/div>\n\n

\n

https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/6\/51_6_595\/_pdf\/-char\/en<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Keiji Ozeki 1, Satoshi Tanida, Takashi Mizushima, Tsutomu Mizoshita, Hironobu Tsukamoto, Yoshikazu Hirata, Kenji Murakami, Takaya Shimura, Hiromi Kataoka, Takeshi Kamiya, Takashi Joh, Intern Med. 2012;51(6):595-9. A 21-year-old Caucasian man with a diagnosis of Crohn’s disease (CD) at the age of 14 was admitted to our hospital due to CD flare-up while under scheduled adalimumab (ADA) maintenance therapy. His symptoms remained virtually unchanged following high dose […]<\/p>\n","protected":false},"template":"","scientific_tags":[215,147,137,135],"class_list":["post-4005","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-adalimumab","scientific_tags-clinical-remission","scientific_tags-ct","scientific_tags-steroid-refractory"],"acf":[],"yoast_head":"\nCombination therapy with Adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn\u2019s disease patient with the loss of response to scheduled Adalimumab maintenance therapy: A case report - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/combination-therapy-with-adalimumab-plus-intensive-granulocyte-and-monocyte-adsorptive-apheresis-induced-clinical-remission-in-a-crohns-disease-patient-with-the-loss-of-response-to-scheduled\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Combination therapy with Adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn\u2019s disease patient with the loss of response to scheduled Adalimumab maintenance therapy: A case report - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Keiji Ozeki 1, Satoshi Tanida, Takashi Mizushima, Tsutomu Mizoshita, Hironobu Tsukamoto, Yoshikazu Hirata, Kenji Murakami, Takaya Shimura, Hiromi Kataoka, Takeshi Kamiya, Takashi Joh, Intern Med. 2012;51(6):595-9. A 21-year-old Caucasian man with a diagnosis of Crohn’s disease (CD) at the age of 14 was admitted to our hospital due to CD flare-up while under scheduled adalimumab (ADA) maintenance therapy. His symptoms remained virtually unchanged following high dose […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/combination-therapy-with-adalimumab-plus-intensive-granulocyte-and-monocyte-adsorptive-apheresis-induced-clinical-remission-in-a-crohns-disease-patient-with-the-loss-of-response-to-scheduled\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-12T07:44:33+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/combination-therapy-with-adalimumab-plus-intensive-granulocyte-and-monocyte-adsorptive-apheresis-induced-clinical-remission-in-a-crohns-disease-patient-with-the-loss-of-response-to-scheduled\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/combination-therapy-with-adalimumab-plus-intensive-granulocyte-and-monocyte-adsorptive-apheresis-induced-clinical-remission-in-a-crohns-disease-patient-with-the-loss-of-response-to-scheduled\/\",\"name\":\"Combination therapy with Adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn\u2019s disease patient with the loss of response to scheduled Adalimumab maintenance therapy: A case report - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2012-04-24T13:09:00+00:00\",\"dateModified\":\"2021-07-12T07:44:33+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/combination-therapy-with-adalimumab-plus-intensive-granulocyte-and-monocyte-adsorptive-apheresis-induced-clinical-remission-in-a-crohns-disease-patient-with-the-loss-of-response-to-scheduled\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Combination therapy with Adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn\u2019s disease patient with the loss of response to scheduled Adalimumab maintenance therapy: A case report - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/combination-therapy-with-adalimumab-plus-intensive-granulocyte-and-monocyte-adsorptive-apheresis-induced-clinical-remission-in-a-crohns-disease-patient-with-the-loss-of-response-to-scheduled\/","og_locale":"es_ES","og_type":"article","og_title":"Combination therapy with Adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn\u2019s disease patient with the loss of response to scheduled Adalimumab maintenance therapy: A case report - Adacyte","og_description":"Keiji Ozeki 1, Satoshi Tanida, Takashi Mizushima, Tsutomu Mizoshita, Hironobu Tsukamoto, Yoshikazu Hirata, Kenji Murakami, Takaya Shimura, Hiromi Kataoka, Takeshi Kamiya, Takashi Joh, Intern Med. 2012;51(6):595-9. A 21-year-old Caucasian man with a diagnosis of Crohn’s disease (CD) at the age of 14 was admitted to our hospital due to CD flare-up while under scheduled adalimumab (ADA) maintenance therapy. His symptoms remained virtually unchanged following high dose […]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/combination-therapy-with-adalimumab-plus-intensive-granulocyte-and-monocyte-adsorptive-apheresis-induced-clinical-remission-in-a-crohns-disease-patient-with-the-loss-of-response-to-scheduled\/","og_site_name":"Adacyte","article_modified_time":"2021-07-12T07:44:33+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/combination-therapy-with-adalimumab-plus-intensive-granulocyte-and-monocyte-adsorptive-apheresis-induced-clinical-remission-in-a-crohns-disease-patient-with-the-loss-of-response-to-scheduled\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/combination-therapy-with-adalimumab-plus-intensive-granulocyte-and-monocyte-adsorptive-apheresis-induced-clinical-remission-in-a-crohns-disease-patient-with-the-loss-of-response-to-scheduled\/","name":"Combination therapy with Adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn\u2019s disease patient with the loss of response to scheduled Adalimumab maintenance therapy: A case report - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2012-04-24T13:09:00+00:00","dateModified":"2021-07-12T07:44:33+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/combination-therapy-with-adalimumab-plus-intensive-granulocyte-and-monocyte-adsorptive-apheresis-induced-clinical-remission-in-a-crohns-disease-patient-with-the-loss-of-response-to-scheduled\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/4005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=4005"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=4005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}